The 2024 Digestive Tumor Fengyun Conference was held to explore the optimization of the whole process of management of advanced colorectal cancer

This article is only for the reference of medical and pharmaceutical professionals practicing in Chinese mainland, if you are not the aforementioned professional, please leave this page

审批码：PP- FR- CN-1203

bibliography

[1] Van K. Morris, et al. 2024 ASCO-GI # 5.

[2] Hiroki Yukami, et al . 2024 ASCO-GI # 6.

[3] Laura Melina Fernandez, et al.2024 ASCO-GI # 7.

[4] Julian Walter Holch, et al. 2024 ASCO-GI#13.

[5] Kota Ouchi, et al. 2024 ASCO-GI#152.

[6] Eleonora Lai, et al. 2024 ASCO-GI#206.

[7] Heinz-Josef Lenz, et al. 2024 ASCO-GI #97.

[8] Thierry Andre, et al.2024 ASCO-GI.#LBA768.

[9] Rui-Hua Xu, et al. 2024 ASCO-GI #124.

[10]2023 CSCO 结直肠癌诊疗指南.

[11] Liu Xingzhou, et al. Medical Review, 2017,23(15):2972-2977.

[12] Sun Q,et al. Cancer Biol Ther. 2014; 15(12):1635-45.

[13] NCCN Clinical Practice Guidelines in Oncology. Colon Cancer.2024 v1.

[14] NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer.2024 v1.

[15] Li J, et al. JAMA. 2018 Jun 26; 319(24):2486-2496.

[16] Xu R, et al. Future Oncol. 2021 Apr; 17(11):1339-1350.

[17] Qin S, et al. Onco Targets Ther. 2021 Aug 11;14:4439-4450.

[18] Arvind Dasari, et al. 2022ESMO,LBA 25.

[19] Jin Y, et al. 2021 CSCO presentation. Abstract oral 28.

[20] Ying Jin, et al. Cancer Management and Research 2021:13 6199–6205

[21] National Drug Catalogue for Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance (2023).

Typography: Squid

Execution: Uni

This platform aims to deliver more medical information to healthcare professionals. The content published on this platform should not be used as a substitute for professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice. If such information is used for purposes other than understanding medical information, the platform does not assume relevant responsibilities. This platform does not mean that it agrees with its descriptions and views on the published content. If copyright issues are involved, please contact us, and we will deal with it as soon as possible.